S&P 500   4,229.45 (-1.37%)
DOW   33,002.38 (-1.29%)
QQQ   354.92 (-1.75%)
AAPL   172.40 (-0.78%)
MSFT   313.39 (-2.61%)
META   300.94 (-1.92%)
GOOGL   132.43 (-1.30%)
AMZN   124.72 (-3.66%)
TSLA   246.53 (-2.02%)
NVDA   435.17 (-2.82%)
NIO   8.61 (-2.05%)
BABA   84.57 (-2.27%)
AMD   100.08 (-3.09%)
T   14.79 (+0.82%)
F   12.07 (-1.95%)
MU   67.83 (-0.19%)
CGC   0.68 (-6.82%)
GE   107.77 (-0.94%)
DIS   79.54 (-2.61%)
AMC   7.86 (-3.56%)
PFE   33.90 (-0.12%)
PYPL   57.30 (-2.15%)
NFLX   376.75 (-0.94%)
S&P 500   4,229.45 (-1.37%)
DOW   33,002.38 (-1.29%)
QQQ   354.92 (-1.75%)
AAPL   172.40 (-0.78%)
MSFT   313.39 (-2.61%)
META   300.94 (-1.92%)
GOOGL   132.43 (-1.30%)
AMZN   124.72 (-3.66%)
TSLA   246.53 (-2.02%)
NVDA   435.17 (-2.82%)
NIO   8.61 (-2.05%)
BABA   84.57 (-2.27%)
AMD   100.08 (-3.09%)
T   14.79 (+0.82%)
F   12.07 (-1.95%)
MU   67.83 (-0.19%)
CGC   0.68 (-6.82%)
GE   107.77 (-0.94%)
DIS   79.54 (-2.61%)
AMC   7.86 (-3.56%)
PFE   33.90 (-0.12%)
PYPL   57.30 (-2.15%)
NFLX   376.75 (-0.94%)
S&P 500   4,229.45 (-1.37%)
DOW   33,002.38 (-1.29%)
QQQ   354.92 (-1.75%)
AAPL   172.40 (-0.78%)
MSFT   313.39 (-2.61%)
META   300.94 (-1.92%)
GOOGL   132.43 (-1.30%)
AMZN   124.72 (-3.66%)
TSLA   246.53 (-2.02%)
NVDA   435.17 (-2.82%)
NIO   8.61 (-2.05%)
BABA   84.57 (-2.27%)
AMD   100.08 (-3.09%)
T   14.79 (+0.82%)
F   12.07 (-1.95%)
MU   67.83 (-0.19%)
CGC   0.68 (-6.82%)
GE   107.77 (-0.94%)
DIS   79.54 (-2.61%)
AMC   7.86 (-3.56%)
PFE   33.90 (-0.12%)
PYPL   57.30 (-2.15%)
NFLX   376.75 (-0.94%)
S&P 500   4,229.45 (-1.37%)
DOW   33,002.38 (-1.29%)
QQQ   354.92 (-1.75%)
AAPL   172.40 (-0.78%)
MSFT   313.39 (-2.61%)
META   300.94 (-1.92%)
GOOGL   132.43 (-1.30%)
AMZN   124.72 (-3.66%)
TSLA   246.53 (-2.02%)
NVDA   435.17 (-2.82%)
NIO   8.61 (-2.05%)
BABA   84.57 (-2.27%)
AMD   100.08 (-3.09%)
T   14.79 (+0.82%)
F   12.07 (-1.95%)
MU   67.83 (-0.19%)
CGC   0.68 (-6.82%)
GE   107.77 (-0.94%)
DIS   79.54 (-2.61%)
AMC   7.86 (-3.56%)
PFE   33.90 (-0.12%)
PYPL   57.30 (-2.15%)
NFLX   376.75 (-0.94%)
Positive News SentimentPositive News
NASDAQ:GTHX

G1 Therapeutics (GTHX) SEC Filings & 10K Form

$1.26
-0.10 (-7.35%)
(As of 10/3/2023 ET)
Compare
Today's Range
$1.24
▼
$1.34
50-Day Range
$1.22
▼
$2.40
52-Week Range
$1.17
▼
$13.85
Volume
550,731 shs
Average Volume
971,310 shs
Market Capitalization
$65.20 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$11.80
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability

Recent G1 Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
09/21/2023
3:15 PM		G1 Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2023
6:28 PM		G1 Therapeutics (Subject)
Velleca Mark A. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/02/2023
5:50 AM		G1 Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/07/2023
3:07 PM		Bailey John E. Jr. (0001806147) (Reporting)
G1 Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/07/2023
3:08 PM		G1 Therapeutics (Issuer)
Malik Rajesh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/07/2023
3:08 PM		G1 Therapeutics (Issuer)
MURDOCK TERRY L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/07/2023
3:08 PM		G1 Therapeutics (Issuer)
Perry Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
3:07 PM		Flowers Cynthia Louise (Reporting)
G1 Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
3:07 PM		G1 Therapeutics (Issuer)
Sharpless Norman (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2023
3:34 PM		G1 Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/24/2023
3:41 PM		G1 Therapeutics (Issuer)
Thomas Monica R. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/12/2023
3:19 PM		G1 Therapeutics (Issuer)
Perry Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2023
3:19 PM		G1 Therapeutics (Issuer)
Umstead John V. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2023
3:19 PM		G1 Therapeutics (Issuer)
Malik Rajesh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2023
3:20 PM		Avagliano Mark (Reporting)
G1 Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2023
3:20 PM		G1 Therapeutics (Issuer)
MURDOCK TERRY L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2023
3:16 PM		Bailey John E. Jr. (0001806147) (Reporting)
G1 Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2023
5:46 AM		G1 Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/14/2023
3:20 PM		G1 Therapeutics (Filer)
Form 10-K/A
03/01/2023
5:37 AM		G1 Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2023
5:30 AM		G1 Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/03/2023
10:47 AM		G1 Therapeutics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
01/09/2023
5:39 AM		G1 Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/05/2023
7:23 PM		Bailey John E. Jr. (0001806147) (Reporting)
G1 Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2023
7:25 PM		G1 Therapeutics (Issuer)
Hanson James S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2023
7:25 PM		Avagliano Mark (Reporting)
G1 Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2023
7:25 PM		G1 Therapeutics (Issuer)
Malik Rajesh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2023
7:25 PM		G1 Therapeutics (Issuer)
Perry Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2023
7:26 PM		G1 Therapeutics (Issuer)
MURDOCK TERRY L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2023
7:26 PM		G1 Therapeutics (Issuer)
Moses Jennifer K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2022
3:12 PM		G1 Therapeutics (Issuer)
Malik Rajesh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2022
9:35 AM		G1 Therapeutics (Subject)
JPMORGAN CHASE & CO (Filed by)
Form SC 13G/A
11/17/2022
3:04 PM		G1 Therapeutics (Filer)
Form 424B5
11/02/2022
3:15 PM		G1 Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/02/2022
5:45 AM		G1 Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/20/2022
3:05 PM		G1 Therapeutics (Issuer)
Velleca Mark A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies:
SEC Filings Tools:
This page (NASDAQ:GTHX) was last updated on 10/3/2023 by MarketBeat.com Staff

My Account -